» Authors » Marianna Nodale

Marianna Nodale

Explore the profile of Marianna Nodale including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 1042
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Uchida L, Jones R, Smith R, Nodale M, Bond S, Loechel C, et al.
Rheumatol Adv Pract . 2024 Aug; 8(3):rkae090. PMID: 39165399
Objectives: Rituximab is used for remission induction and the prevention of relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). This study evaluated the incidence of safety events and compared time to...
2.
Hall F, Cheriyan J, Cope A, Galloway J, Wilkinson I, Bond S, et al.
Lancet Respir Med . 2023 Nov; 11(12):1064-1074. PMID: 37977159
Background: From early in the COVID-19 pandemic, evidence suggested a role for cytokine dysregulation and complement activation in severe disease. In the TACTIC-R trial, we evaluated the efficacy and safety...
3.
Smith R, Jones R, Specks U, Bond S, Nodale M, Al-Jayyousi R, et al.
Ann Rheum Dis . 2023 Mar; 82(7):937-944. PMID: 36958796
Objective: Following induction of remission with rituximab in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) relapse rates are high, especially in patients with history of relapse. Relapses are associated with increased exposure...
4.
Davies B, Mowforth O, Yordanov S, Alvarez-Berdugo D, Bond S, Nodale M, et al.
BMJ Open . 2023 Mar; 13(3):e061294. PMID: 36882259
Introduction: Degenerative cervical myelopathy (DCM) is a common and disabling condition of symptomatic cervical spinal cord compression secondary to degenerative changes in spinal structures leading to a mechanical stress injury...
5.
Smith R, Jones R, Specks U, Bond S, Nodale M, Aljayyousi R, et al.
Ann Rheum Dis . 2020 Jun; 79(9):1243-1249. PMID: 32581088
Objectives: Evaluation of rituximab and glucocorticoids as therapy to induce remission after relapse in ANCA-associated vasculitis (AAV) in a prospective observational cohort of patients enrolled into the induction phase of...
6.
Barnard K, Wysocki T, Allen J, Elleri D, Thabit H, Leelarathna L, et al.
BMJ Open Diabetes Res Care . 2014 Dec; 2(1):e000025. PMID: 25452866
Objective: To explore the experiences of adolescents with type 1 diabetes mellitus (T1DM) and their parents taking part in an overnight closed loop study at home, using qualitative and quantitative...
7.
Leelarathna L, Dellweg S, Mader J, Allen J, Benesch C, Doll W, et al.
Diabetes Care . 2014 Jun; 37(7):1931-7. PMID: 24963110
Objective: To evaluate the feasibility of day and night closed-loop insulin delivery in adults with type 1 diabetes under free-living conditions. Research Design And Methods: Seventeen adults with type 1...
8.
Thabit H, Lubina-Solomon A, Stadler M, Leelarathna L, Walkinshaw E, Pernet A, et al.
Lancet Diabetes Endocrinol . 2014 Jun; 2(9):701-9. PMID: 24943065
Background: Closed-loop insulin delivery is a promising option to improve glycaemic control and reduce the risk of hypoglycaemia. We aimed to assess whether overnight home use of automated closed-loop insulin...
9.
Leelarathna L, Thabit H, Allen J, Nodale M, Wilinska M, Powell K, et al.
J Diabetes Sci Technol . 2014 May; 8(2):267-272. PMID: 24876577
The objective was to assess the reliability of a novel automated closed-loop glucose control system developed within the AP@home consortium in adults with type 1 diabetes. Eight adults with type...
10.
Hovorka R, Elleri D, Thabit H, Allen J, Leelarathna L, El-Khairi R, et al.
Diabetes Care . 2014 Apr; 37(5):1204-11. PMID: 24757227
Objective: To evaluate feasibility, safety, and efficacy of overnight closed-loop insulin delivery in free-living youth with type 1 diabetes. Research Design And Methods: Overnight closed loop was evaluated at home...